Cargando…
Optimizing Dendritic Cell-Based Approaches for Cancer Immunotherapy
Dendritic cells (DC) are professional antigen-presenting cells uniquely suited for cancer immunotherapy. They induce primary immune responses, potentiate the effector functions of previously primed T-lymphocytes, and orchestrate communication between innate and adaptive immunity. The remarkable dive...
Autores principales: | Datta, Jashodeep, Terhune, Julia H., Lowenfeld, Lea, Cintolo, Jessica A., Xu, Shuwen, Roses, Robert E., Czerniecki, Brian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257036/ https://www.ncbi.nlm.nih.gov/pubmed/25506283 |
Ejemplares similares
-
Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
por: Datta, Jashodeep, et al.
Publicado: (2015) -
Oncodriver inhibition and CD4(+) Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies
por: Rosemblit, Cinthia, et al.
Publicado: (2018) -
Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination
por: Datta, Jashodeep, et al.
Publicado: (2014) -
Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer
por: Datta, Jashodeep, et al.
Publicado: (2015) -
Vaccine Development: How Scientific Collaboration and Communication Help Prevent the Spread of Disease: An Interview with Erol Fikrig, MD
por: Turchick, Audrey, et al.
Publicado: (2014)